Identification of RUVBL2 as a novel biomarker to predict the prognosis and drug sensitivity in multiple myeloma based on ferroptosis genes
Background Multiple myeloma (MM) is a hematological malignancy with the proliferation of malignant plasma cells. Numerous studies have highlighted the critical role of ferroptosis in MM. However, how to use ferroptosis-related genes (FRGs) for prognostic prediction and treatment guidance in MM remai...
Saved in:
| Main Authors: | Sishi Tang, Xinyi Long, Fangfang Li, Siyi Jiang, Yunfeng Fu, Jing Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Hematology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/16078454.2025.2467499 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of HIST1H2BH as the hub gene associated with multiple myeloma using integrated bioinformatics analysis
by: Wenxue Zhang, et al.
Published: (2024-12-01) -
Molecular analysis to identify novel potential biomarkers as drug targets in colorectal cancer therapy: an integrated bioinformatics analysis
by: Mansour K. Gatasheh, et al.
Published: (2024-12-01) -
Hub genes and associated drugs for multiple myeloma with 1q21+: identified by bioinformatic analysis
by: Zhiqiang Xu, et al.
Published: (2024-12-01) -
Identifying and validating PLAU as a potential prognostic biomarker for PDAC
by: Peng An, et al.
Published: (2025-04-01) -
Identification of crucial pathways and genes linked to endoplasmic reticulum stress in PCOS through combined bioinformatic analysis
by: Yan Zhang, et al.
Published: (2025-01-01)